Pediatric PET/MR Image Registry
Sponsor: National Cancer Institute (NCI)
This observational or N/A phase trial investigates Lymphoma and Osteosarcoma and is currently actively recruiting participants. National Cancer Institute (NCI) leads this study, which shows 16 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
16 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Dec 2025 — Feb 2026 [monthly]
Recruiting
-
Jun 2025 — Dec 2025 [monthly]
Recruiting
-
Jan 2025 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
▶ Show 11 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Dec 2023 [monthly]
Recruiting
-
Oct 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2020 — Dec 2020 [monthly]
Recruiting
-
Jul 2019 — Feb 2020 [monthly]
Recruiting
-
Jun 2018 — Jul 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Recruiting NA
First recorded
Feb 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .